These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes. Lovshin JA; Barnie A; DeAlmeida A; Logan A; Zinman B; Drucker DJ Diabetes Care; 2015 Jan; 38(1):132-9. PubMed ID: 25414155 [TBL] [Abstract][Full Text] [Related]
6. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers. Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082 [TBL] [Abstract][Full Text] [Related]
7. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948 [TBL] [Abstract][Full Text] [Related]
8. Renal and hormonal effects and tolerance of an ANP analogue in healthy man. Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038 [TBL] [Abstract][Full Text] [Related]
9. Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study. Pedersen EB; Thomsen IM; Fjordside LS Am J Hypertens; 2005 Dec; 18(12 Pt 1):1578-85. PubMed ID: 16364829 [TBL] [Abstract][Full Text] [Related]
10. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. Tonneijck L; Smits MM; Muskiet MHA; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH Diabetologia; 2016 Jul; 59(7):1412-1421. PubMed ID: 27038451 [TBL] [Abstract][Full Text] [Related]
11. Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment. von Scholten BJ; Lajer M; Goetze JP; Persson F; Rossing P Diabet Med; 2015 Mar; 32(3):343-52. PubMed ID: 25251901 [TBL] [Abstract][Full Text] [Related]
12. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Tonneijck L; Smits MM; Muskiet MH; Hoekstra T; Kramer MH; Danser AH; Ter Wee PM; Diamant M; Joles JA; van Raalte DH Diabetes Care; 2016 Nov; 39(11):2042-2050. PubMed ID: 27585605 [TBL] [Abstract][Full Text] [Related]
13. Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats. Zhou X; Huang CH; Lao J; Pocai A; Forrest G; Price O; Roy S; Kelley DE; Sullivan KA; Forrest MJ Cardiovasc Diabetol; 2015 Mar; 14():29. PubMed ID: 25888997 [TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects. Nielsen CB; Pedersen EB J Intern Med; 1994 Apr; 235(4):359-65. PubMed ID: 8151269 [TBL] [Abstract][Full Text] [Related]
15. The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients. Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; van Raalte DH Diabetes Res Clin Pract; 2017 Feb; 124():1-10. PubMed ID: 28086201 [TBL] [Abstract][Full Text] [Related]
16. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes. Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB Scand J Clin Lab Invest; 2014 Jan; 74(1):8-19. PubMed ID: 24256611 [TBL] [Abstract][Full Text] [Related]
17. The effect of liraglutide on renal function: A randomized clinical trial. von Scholten BJ; Persson F; Rosenlund S; Hovind P; Faber J; Hansen TW; Rossing P Diabetes Obes Metab; 2017 Feb; 19(2):239-247. PubMed ID: 27753201 [TBL] [Abstract][Full Text] [Related]
18. Normotensive sodium loading in normal man: regulation of renin secretion during beta-receptor blockade. Mølstrøm S; Larsen NH; Simonsen JA; Washington R; Bie P Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R436-45. PubMed ID: 19073901 [TBL] [Abstract][Full Text] [Related]
19. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans. Bruun NE; Skøtt P; Giese J Am J Physiol; 1991 Jan; 260(1 Pt 2):R217-24. PubMed ID: 1847023 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system. Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]